tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BBIO Stock Latest News

BridgeBio price target raised to $84 from $76 at Wells Fargo
The FlyBridgeBio price target raised to $84 from $76 at Wells Fargo
20d ago
BBIO
BridgeBio presents data from ATTRibute-CM study on acoramidis
PremiumThe Fly
BridgeBio presents data from ATTRibute-CM study on acoramidis
21d ago
BBIO
BridgeBio price target raised to $77 from $76 at JPMorgan
PremiumThe Fly
BridgeBio price target raised to $77 from $76 at JPMorgan
24d ago
BBIO
BridgeBio price target raised to $100 from $55 at Goldman Sachs
PremiumThe Fly
BridgeBio price target raised to $100 from $55 at Goldman Sachs
1M ago
BBIO
BridgeBio Pharma’s Earnings Call Highlights Success and Challenges
PremiumCompany Announcements
BridgeBio Pharma’s Earnings Call Highlights Success and Challenges
1M ago
BBIO
BridgeBio price target raised to $80 from $66 at Truist
PremiumThe FlyBridgeBio price target raised to $80 from $66 at Truist
1M ago
BBIO
BridgeBio price target raised to $95 from $60 at TD Cowen
Premium
The Fly
BridgeBio price target raised to $95 from $60 at TD Cowen
1M ago
BBIO
BridgeBio price target raised to $81 from $73 at Oppenheimer
Premium
The Fly
BridgeBio price target raised to $81 from $73 at Oppenheimer
1M ago
BBIO
BridgeBio price target raised to $98 from $93 at Piper Sandler
PremiumThe Fly
BridgeBio price target raised to $98 from $93 at Piper Sandler
1M ago
BBIO
BridgeBio Pharma Reports Strong Q3 2025 Results
PremiumCompany Announcements
BridgeBio Pharma Reports Strong Q3 2025 Results
1M ago
BBIO
BridgeBio Pharma Reports Positive Phase 3 Study Results
PremiumCompany Announcements
BridgeBio Pharma Reports Positive Phase 3 Study Results
1M ago
8K
BBIO
BridgeBio reports Q3 EPS (95c), consensus (78c)
PremiumThe Fly
BridgeBio reports Q3 EPS (95c), consensus (78c)
1M ago
BBIO
BridgeBio price target raised to $90 from $80 at H.C. Wainwright
PremiumThe FlyBridgeBio price target raised to $90 from $80 at H.C. Wainwright
1M ago
BBIO
BridgeBio announces Phase 3 study of encaleret met primary endpoint
Premium
The Fly
BridgeBio announces Phase 3 study of encaleret met primary endpoint
1M ago
BBIO
Optimistic Buy Rating for BridgeBio Pharma: Promising Phase 3 Trial Results and Future Developments
Premium
Ratings
Optimistic Buy Rating for BridgeBio Pharma: Promising Phase 3 Trial Results and Future Developments
1M ago
BBIO
BridgeBio price target raised to $76 from $58 at BofA
PremiumThe Fly
BridgeBio price target raised to $76 from $58 at BofA
1M ago
BBIO
BridgeBio price target raised to $80 from $70 at H.C. Wainwright
PremiumThe Fly
BridgeBio price target raised to $80 from $70 at H.C. Wainwright
1M ago
BBIO
Positive Outlook for BridgeBio Pharma: Buy Rating Affirmed on Strong Phase 3 Trial Results and Strategic Market Positioning
PremiumRatings
Positive Outlook for BridgeBio Pharma: Buy Rating Affirmed on Strong Phase 3 Trial Results and Strategic Market Positioning
1M ago
BBIO
BridgeBio Pharma Announces Positive Phase 3 Study Results
PremiumCompany Announcements
BridgeBio Pharma Announces Positive Phase 3 Study Results
1M ago
8K
BBIO
BridgeBio Pharma’s Promising Phase 3 Results and Accelerated Approval Path Justify Buy Rating
PremiumRatingsBridgeBio Pharma’s Promising Phase 3 Results and Accelerated Approval Path Justify Buy Rating
1M ago
BBIO
BridgeBio price target raised to $69 from $59 at Raymond James
Premium
The Fly
BridgeBio price target raised to $69 from $59 at Raymond James
1M ago
BBIO
Midday Fly By: Novartis to buy Avidity, Keurig Dr Pepper beats expectations
Premium
The Fly
Midday Fly By: Novartis to buy Avidity, Keurig Dr Pepper beats expectations
1M ago
C
NP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >